We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Ashland
ASH
$3.36B
| $1.1M | ﹤0.01% |
12,700
| – | – |
|
902
Axsome Therapeutics
AXSM
$11.2B
| $1.1M | ﹤0.01% |
12,300
+2,000
| +19% | +$175K |
|
903
Macerich
MAC
$6.99B
| $1.1M | ﹤0.01% |
60,556
| – | – |
|
|
NSA
904
DELISTED
National Storage Affiliates Trust
NSA
| $1.1M | ﹤0.01% |
22,916
+6,100
| +36% | +$272K |
|
905
Celsius Holdings
CELH
$7.28B
| $1.1M | ﹤0.01% |
35,200
-600
| -2% | -$25.2K |
|
906
GATX Corp
GATX
$6.33B
| $1.1M | ﹤0.01% |
8,330
+1,300
| +18% | +$179K |
|
|
EFOR
907
Everforth Inc
EFOR
$1.37B
| $1.1M | ﹤0.01% |
11,823
+2,600
| +28% | +$241K |
|
908
LXP Industrial Trust
LXP
$3.58B
| $1.1M | ﹤0.01% |
21,883
+6,040
| +38% | +$301K |
|
909
Qualys
QLYS
$6.78B
| $1.1M | ﹤0.01% |
8,551
+1,600
| +23% | +$211K |
|
910
Tenable Holdings
TENB
$4.41B
| $1.1M | ﹤0.01% |
27,100
+3,400
| +14% | +$142K |
|
911
FirstCash
FCFS
$9.14B
| $1.09M | ﹤0.01% |
9,516
+1,100
| +13% | +$125K |
|
912
Huntsman Corp
HUN
$1.81B
| $1.09M | ﹤0.01% |
45,113
+13,600
| +43% | +$302K |
|
913
AutoNation
AN
$6.89B
| $1.09M | ﹤0.01% |
6,100
| – | – |
|
914
Axcelis
ACLS
$4.42B
| $1.09M | ﹤0.01% |
10,400
+2,900
| +39% | +$339K |
|
915
Cousins Properties
CUZ
$4.93B
| $1.08M | ﹤0.01% |
36,620
+4,500
| +14% | +$121K |
|
916
Neogen
NEOG
$2.59B
| $1.08M | ﹤0.01% |
64,264
+6,600
| +11% | +$109K |
|
917
SL Green Realty
SLG
$4.08B
| $1.08M | ﹤0.01% |
15,465
| – | – |
|
|
CADE
918
DELISTED
Cadence Bank
CADE
| $1.07M | ﹤0.01% |
33,658
| – | – |
|
|
AXNX
919
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.07M | ﹤0.01% |
15,400
| – | – |
|
920
Piper Sandler
PIPR
$5.54B
| $1.07M | ﹤0.01% |
15,088
| – | – |
|
921
Coty
COTY
$2.42B
| $1.07M | ﹤0.01% |
113,900
+22,300
| +24% | +$213K |
|
922
Home BancShares
HOMB
$6.27B
| $1.06M | ﹤0.01% |
39,155
| – | – |
|
923
Brink's
BCO
$4.72B
| $1.06M | ﹤0.01% |
9,137
| – | – |
|
924
American States Water
AWR
$3.52B
| $1.06M | ﹤0.01% |
12,676
+3,200
| +34% | +$258K |
|
925
California Water Service
CWT
$3.1B
| $1.05M | ﹤0.01% |
19,454
+4,000
| +26% | +$212K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.